StocksUpdated×2•Originally published 19 June 2026•Updated 20 June 2026•
1 min read
Regencell Faces Class-Action Complaint Over Alleged Misleading Disclosures
Key Facts
1Bronstein, Gewirtz & Grossman, LLC filed a class action lawsuit against Regencell Bioscience Holdings Ltd. alleging false and misleading statements.
Regencell Bioscience faces a class-action complaint alleging misleading disclosures about market-manipulation risk and the company’s financial position during the class period.
The claims remain unproven unless adjudicated or settled, so the story should present legal risk cautiously without implying established wrongdoing.
Investors should monitor lead-plaintiff deadlines, any company response, and later disclosures that could affect RGC.